$Sage Therapeutics (SAGE.US)$Sage Therapeutics Inc: Sage-324 (Biib124) Did Not Demonstrate a Statistically Significant Dose-Response Relationship on Primary Endpoint
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
4
Translate
Report
5253 Views
Comment
Sign in to post a comment
Trytosaveabit
OP
:
Sage Therapeutics Inc: Do Not Plan to Conduct Further Clinical Development of Sage-324 in Et
Trytosaveabit OP : Sage Therapeutics Inc: Do Not Plan to Conduct Further Clinical Development of Sage-324 in Et
买跌不追涨 : Can't go short
Trytosaveabit OP 买跌不追涨 : Sorry. I won’t go short. Don’t believe in it personally! GL
买跌不追涨 Trytosaveabit OP : I also seldom go short